The incidence of skip metastases on whole bone MRI in high-grade bone sarcomas.


Journal

Skeletal radiology
ISSN: 1432-2161
Titre abrégé: Skeletal Radiol
Pays: Germany
ID NLM: 7701953

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 07 08 2019
accepted: 29 12 2019
revised: 21 12 2019
pubmed: 11 1 2020
medline: 9 2 2021
entrez: 11 1 2020
Statut: ppublish

Résumé

Skip metastases have been described with osteosarcoma, Ewing sarcoma and rarely chondrosarcoma. The aim of this study was to determine the incidence of skip metastases on whole bone MRI in all primary high-grade sarcomas of the major long bones. Retrospective review of patients from April 2007 to April 2019 with high-grade primary bone sarcomas of the humerus, radius, ulna, femur, tibia or fibula who had whole bone MRI at initial staging. Data collected included age, sex, tumour type, presence and location of skip metastases based on whole bone MRI and presence of distant metastases (the skeleton and lung). The study included 216 males and 171 females with mean age 30.6 years (range 4-92 years). Tumour types were as follows: High-grade osteosarcoma n = 202, Ewing sarcoma n = 68, high-grade chondrosarcoma n = 44, dedifferentiated chondrosarcoma n = 37, high-grade spindle cell sarcoma n = 29 and angiosarcoma n = 7. Skip lesions were identified in 63 (16.3%). However, after taking into account the presence of distant skeletal (n = 11) and pulmonary (n = 33) metastases, the overall incidence of skip metastases was 6.5%, occurring in 15 (7.5%) high-grade osteosarcomas, 3 (4.5%) Ewing sarcoma, 1 (2.8%) high-grade chondrosarcoma, 4 (10.8%) dedifferentiated chondrosarcomas, and 2 (6.9%) high-grade spindle cell sarcomas. A false positive MRI diagnosis of skip metastasis was made in 4 cases, 3 enchondromata and one focal nodular marrow hyperplasia. The current study has documented the incidence of skip metastases in common types of high-grade primary bone sarcoma. The possibility of false positive skip metastases has also been highlighted.

Identifiants

pubmed: 31919587
doi: 10.1007/s00256-019-03369-9
pii: 10.1007/s00256-019-03369-9
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

945-954

Références

J Clin Oncol. 2006 Apr 1;24(10):1535-41
pubmed: 16575004
J Nucl Med. 2003 Jun;44(6):930-42
pubmed: 12791822
J Bone Joint Surg Am. 1990 Jan;72(1):60-8
pubmed: 2295674
Cancer. 1975 Dec;36(6):2192-205
pubmed: 1060507
AJR Am J Roentgenol. 2008 Jun;190(6):1611-5
pubmed: 18492914
Clin Radiol. 2017 Mar;72(3):265.e7-265.e23
pubmed: 27889090
Skeletal Radiol. 2019 Apr;48(4):503-516
pubmed: 30288560
Clin Orthop Relat Res. 2004 Sep;(426):92-6
pubmed: 15346057
Insights Imaging. 2014 Aug;5(4):419-40
pubmed: 25005774
PLoS One. 2017 Mar 16;12(3):e0173665
pubmed: 28301537
Pediatr Blood Cancer. 2016 Aug;63(8):1381-6
pubmed: 27082077
Skeletal Radiol. 1997 Jun;26(6):379-84
pubmed: 9229423
Australas Radiol. 1995 Aug;39(3):303-5
pubmed: 7487772
Clin Orthop Relat Res. 1996 Jul;(328):211-9
pubmed: 8653959
Clin Imaging. 2011 Sep-Oct;35(5):378-84
pubmed: 21872128
J Bone Joint Surg Br. 2011 Sep;93(9):1271-8
pubmed: 21911541
J Surg Oncol. 2017 Aug;116(2):252-257
pubmed: 28420036
Eur J Cancer. 2007 Sep;43(14):2060-5
pubmed: 17720491
Am J Clin Oncol. 2014 Dec;37(6):528-34
pubmed: 23466575
Skeletal Radiol. 2019 Dec;48(12):1861-1874
pubmed: 31309243
Acta Orthop. 2005 Dec;76(6):899-903
pubmed: 16470449
Cancer. 2006 Jun 15;106(12):2682-91
pubmed: 16691621
Clin Orthop Relat Res. 1975 Sep;(111):33-41
pubmed: 1057464
Rare Tumors. 2013 Sep 17;5(3):e53
pubmed: 24179665

Auteurs

Asif Saifuddin (A)

Department of Imaging, Royal National Orthopaedic Hospital, Stanmore, UK.

Ban Sharif (B)

Department of Imaging, Northwick Park Hospital, Harrow, UK. ban.sharif@nhs.net.

Ines Oliveira (I)

Department of Imaging, Royal National Orthopaedic Hospital, Stanmore, UK.

Sarah Kalus (S)

Department of Imaging, Royal National Orthopaedic Hospital, Stanmore, UK.

James Barnett (J)

Department of Orthopaedics, Royal National Orthopaedic Hospital, Stanmore, UK.

Ian Pressney (I)

Department of Imaging, Royal National Orthopaedic Hospital, Stanmore, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH